Over 140 guests, crew sick due to a gastrointestinal outbreak on this popular cruise line
Among the 3,914 guests aboard its Navigator of the Seas ship, 134 reported being ill during a cruise that ended July 11, along with seven crew members, according to the Centers for Disease Control and Prevention. Their main symptoms were vomiting, abdominal cramps and diarrhea.
The health agency listed the causative agent as unknown. The ship was sailing a week-long cruise to Mexico round-trip from Los Angeles, according to CruiseMapper.
The cruise line implemented heightened disinfection and cleaning measures and isolated sick guests and crew, among other steps, the CDC said.
'The health and safety of our guests, crew, and the communities we visit are our top priority,' a spokesperson for Royal Caribbean Group, the line's parent company, told USA TODAY in an emailed statement. 'To maintain an environment that supports the highest levels of health and safety onboard our ships, we implement rigorous cleaning procedures, many of which far exceed public health guidelines.'
There have been 18 outbreaks of gastrointestinal illness on cruises that met the CDC's threshold for public notification in 2025, most of which were caused by norovirus. There were 18 outbreaks total last year, and 14 in 2023.
The CDC told USA TODAY in April that while 'the number of recent cruise ship outbreaks has been higher than in years prior to the pandemic, we do not yet know if this represents a new trend.'
'However, CDC data show a newly dominant strain is currently associated with reported norovirus outbreaks on land,' the agency said in an emailed statement. 'Ships typically follow the pattern of land-based outbreaks, which are higher this norovirus season.'
The illness is often associated with cruise ships, but those represent only 1% of all outbreaks reported.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
What to know about chikungunya virus in China as US issues travel alert
The U.S. Centers for Disease Control and Prevention has issued a travel warning following an outbreak of a mosquito-borne illness called chikungunya in China. The CDC's warning centers on Guangdong Province, where the outbreak has exceeded 7,000 confirmed cases since June 2025, according to Chinese health officials. The outbreak in Guangdong Province has been linked to monsoon flooding, which created ideal breeding conditions for mosquitoes, which spread the virus that causes chikungunya. In the new travel warning, the CDC emphasized that vaccination is available and recommended for travelers. Dr. Todd Ellerin, chief of infectious disease at South Shore Health in Massachusetts, told ABC News that travelers to the region "should absolutely take precautions" against the illness. "Wear long sleeves and pants, use insect repellent with DEET, and use mosquito netting for babies too young for repellent," said Ellerin, who is not affiliated with the CDC. Here is what to know about the illness. How common is chikungunya? Chikungunya is not a new infection. It has been around since the 1950s, with outbreaks more commonly seen in tropical areas in recent decades. Globally, there have been about 240,000 infections since the start of 2025, according to the European Centre for Disease Prevention and Control. Chikungunya is not common in the United States. The CDC says there have not been any reported locally acquired cases since 2019. What are the symptoms of chikungunya? According to the CDC, common symptoms of the virus include sudden-onset high fever, severe joint pain (especially in the hands, wrists, ankles, and feet), muscle pain, headache, fatigue and skin rash. Georgia woman describes crippling pain of chikungunya virus Most people recover without medical intervention within seven to 10 days, but in some cases, symptoms can persist for weeks or months. What is the incubation period for chikungunya? Chikungunya typically has an incubation period of less than one week, according to Ellerin. "If it's been more than a week since you left a high-risk area, you're likely in the clear," he said. How is chikungunya treated? There is no specific antiviral treatment for chikungunya. Instead, care focuses on relieving symptoms while the body recovers. The CDC recommends rest, fluids, and medications like acetaminophen for pain and fever. NSAIDs may be used once dengue, another mosquito-borne disease, has been ruled out. Deaths from chikungunya are rare, according to the CDC. Is there a vaccine for chikungunya? There are two vaccines available in the U.S. that begin offering protection within about two weeks of a single dose. Cases of mosquito-borne viruses on the rise The CDC recommends vaccination for travelers visiting areas with active outbreaks, people spending extend time abroad -- typically six months or longer -- and laboratory workers who handle the virus. What contributes to the spread of chikungunya? Climate change is a major driver of chikungunya's global spread. "Warmer temperatures and increased rainfall are helping Aedes mosquitoes expand into new regions," Dr. Krutika Kuppalli of the division of infectious diseases at the University of Texas Southwestern Medical Center told ABC News. Veer Patel, M.D., is an emergency medicine doctor at Maimonides Medical Center and a member of the ABC News Medical Unit. Solve the daily Crossword
4 hours ago
What to know about chikungunya virus amid new outbreak in China
The U.S. Centers for Disease Control and Prevention has issued a travel warning following an outbreak of a mosquito-borne illness called chikungunya in China. The CDC's warning centers on Guangdong Province, where the outbreak has exceeded 7,000 confirmed cases since June 2025, according to Chinese health officials. The outbreak in Guangdong Province has been linked to monsoon flooding, which created ideal breeding conditions for mosquitoes, which spread the virus that causes chikungunya. In the new travel warning, the CDC emphasized that vaccination is available and recommended for travelers. Dr. Todd Ellerin, chief of infectious disease at South Shore Health in Massachusetts, told ABC News that travelers to the region "should absolutely take precautions" against the illness. "Wear long sleeves and pants, use insect repellent with DEET, and use mosquito netting for babies too young for repellent," said Ellerin, who is not affiliated with the CDC. Here is what to know about the illness. How common is chikungunya? Chikungunya is not a new infection. It has been around since the 1950s, with outbreaks more commonly seen in tropical areas in recent decades. Globally, there have been about 240,000 infections since the start of 2025, according to the European Centre for Disease Prevention and Control. Chikungunya is not common in the United States. The CDC says there have not been any reported locally acquired cases since 2019. What are the symptoms of chikungunya? According to the CDC, common symptoms of the virus include sudden-onset high fever, severe joint pain (especially in the hands, wrists, ankles, and feet), muscle pain, headache, fatigue and skin rash. Most people recover without medical intervention within seven to 10 days, but in some cases, symptoms can persist for weeks or months. What is the incubation period for chikungunya? Chikungunya typically has an incubation period of less than one week, according to Ellerin. "If it's been more than a week since you left a high-risk area, you're likely in the clear," he said. How is chikungunya treated? There is no specific antiviral treatment for chikungunya. Instead, care focuses on relieving symptoms while the body recovers. The CDC recommends rest, fluids, and medications like acetaminophen for pain and fever. NSAIDs may be used once dengue, another mosquito-borne disease, has been ruled out. Deaths from chikungunya are rare, according to the CDC. Is there a vaccine for chikungunya? There are two vaccines available in the U.S. that begin offering protection within about two weeks of a single dose. The CDC recommends vaccination for travelers visiting areas with active outbreaks, people spending extend time abroad -- typically six months or longer -- and laboratory workers who handle the virus. What contributes to the spread of chikungunya? Climate change is a major driver of chikungunya's global spread. "Warmer temperatures and increased rainfall are helping Aedes mosquitoes expand into new regions," Dr. Krutika Kuppalli of the division of infectious diseases at the University of Texas Southwestern Medical Center told ABC News.
Fox News
4 hours ago
- Fox News
Mosquito-borne virus spreading through China causes high fever, joint pain
A mosquito-borne virus has led to a widespread outbreak in China, sparking concerns about global impact. The U.S. Centers for Disease Control and Prevention (CDC) has issued a Level 2 alert for an outbreak of chikungunya virus in the Guangdong Province, where health officials have reported more than 7,000 cases as of Wednesday, per the AP. The virus spreads when a mosquito feeds on an infected person and then bites another person. There are efforts underway to control the mosquitoes spreading the virus, including the use of nets, insecticide and drones, the report stated. Chikungunya cases have also been spreading throughout Europe, according to the European Centre for Disease Prevention and Control (ECDC). Since the beginning of 2025, approximately 240,000 CHIKVD cases and 90 deaths have been reported in 16 countries and territories, including the Americas, Africa, Asia and Europe, the health agency reported in July. There have been no confirmed locally acquired cases in the U.S. since 2019, according to CDC data. Common symptoms of chikungunya include high fever and joint pain, according to Dr. Marc Siegel, Fox News senior medical analyst. They usually begin between three and seven days after being bitten by an infected mosquito. Some people may also experience headache, joint swelling, rash and muscle pain, the CDC stated. In most cases, symptoms abate within a week, but some may suffer from severe joint pain for months or years after infection. "Occasionally, neurological complications arise, including encephalitis (swelling of the brain)." "Occasionally, neurological complications arise, including encephalitis (swelling of the brain)," Siegel cautioned. People at highest risk of severe illness include adults 65 and older, newborns and people with comorbidities, such as heart disease or diabetes, the CDC said. Chikungunya is rarely fatal. The chikungunya virus is not transmitted among humans, and cannot be spread through physical contact, coughing or sneezing, the CDC stated. While there have been cases of chikungunya in Southeast Asia, the high volume in Southern China is new, Siegel noted. "China's strategy for containment is also very restrictive and draconian, and won't likely work," he told Fox News Digital. The country has shared plans to use drones to seek out standing water where mosquitoes breed, as well as spraying parks, public places and even people with insect repellents, the doctor said. "Officials are going door to door dressed in red vests and fining or arresting anyone who has still water," Siegel said, citing a New York Times report. "They are also quarantining sick people in the hospital for a week under mosquito netting." Another tactic is using elephant mosquitoes, which produce larvae that eat the Aedes mosquitoes that spread the virus, Siegel added. "None of this is likely to work, as people live too close together and these mosquitoes breed easily," he said. There are not currently any specific medications to treat chikungunya virus. The best way to keep the virus at bay is to prevent mosquito bites, according to experts. Recommended prevention strategies include using EPA-registered insect repellent, wearing long-sleeved shirts and pants, keeping screens on windows, using mosquito netting if sleeping outside, and treating clothing and gear with 0.5% permethrin (a synthetic chemical used primarily as an insecticide). For more Health articles, visit Two vaccines are available in the U.S. — a live-attenuated vaccine (IXCHIQ) and a virus-like particle vaccine (VIMKUNYA), which may be recommended for higher-risk travelers who plan to visit places where the virus is prevalent, the CDC stated. Travelers should speak with a healthcare provider to determine whether they are candidates for the vaccine.
